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Introduction
Nasopharyngeal carcinoma (NPC) is a form of malignant squamous cell carcinoma which arises from epithelial cells of the nasopharynx. It is unusually prevalent in southern China and in other populations of Cantonese origin, where it has an incidence rate of 20
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Lentivirus transductionand oligonucleotide transfection miR-200b was purchased from Origin (Beijing, China). Constructs containing the pre-miR-200b sequence together with 100 bases of the upstream and downstream flanking sequences were cloned into the pGCSIL-GFP vector. C666-1 or 5-8F cells (5 × 10 5 ) were infected with 5 × 10 7 lentiviral units in the presence of 10 µg/mL polybrene. Empty lentiviral vector was used as the negative control. Both miR200b inhibitor and negative control were synthesized by RiBo Bio (Guangzhou, China). Transfection with inhibitor or negative control was performed using Lipofectamine 2000 (Invitrogen) for 48 h, according to the manufacturer's instructions.
Plasmid construction and luciferase reporter assays
A 487-bp fragment from the Notch1 3'UTR (position 509-995) containing the binding sequences of miR-200b was amplified by PCR from a human cDNA library. The fragment was then cloned into the pGL3-control vector (Promega) downstream of the firefly luciferase gene. The predicted miR-200b binding site was mutated using the QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). C666-1 or 5-8F cells were cotransfected with pGL3-Notch1 or pGL3-control vector, together with miR-200b or control vector. After 48 h of culture, the transfected cells were assayed using the dual luciferase reporter assay system (Promega) with a MicroLumatPlus LB96V luminometer (Berthold Technologies, Bad Wildbad, Germany).
Cell proliferation assays
Cell proliferation was assessed using the MTT cell viability assay. Following transfection for 48 h, cells were collected and seeded into new 96-well plates at 2,000 cells/well then cultured for 24, 48, 72 or 96 h. MTT solution was then added to each well to a final concentration of 0.2 mg MTT/mL and the plates were incubated at 37°C for a further 1 h. At the end of the incubation the formazan was dissolved by the addition of 200 µL dimethyl sulfoxide and the absorbance was measured at 450 nm using a spectrophotometer.
Cell migration and invasion assays
Wound healing assays were used to examine migration of NPC cells. C666-1 or 5-8F cells, untransfected or transfected with miR-200b, were cultured until confluent and then a sterile 200 µL pipette tip was used to scrape a clear line through the cell layer. Cultures were returned to the incubator for a further 48 h, at the end of which the cultures were photographed under a light microscope and the distance between the migration fronts was measured. Migration rate was expressed as the percentage wound closure [23] . To quantify invasion, 1× 10 5 C666-1 or 5-8F cells, untreated or transfected with miR-200b or anti-miR-200b as shown, were plated into a BD Biocoat™ Matrigel™ invasion chamber (BD Biosciences) consisting of a multiwell plate with cell culture inserts containing an 8 micron pore size PET membrane overlaid with a thin layer of Matrigel™ basement membrane matrix which blocks non-invasive cells from migrating through the membrane. FBS was added to the lower wells as a chemoattractant and the plates were incubated for 48 h, at the end of which non-invading cells were removed from the upper surface with a cotton swab. Invasive cells on the lower side of the membrane were then stained with crystal violet, air dried and photographed, and the number of stained cells was counted [23] .
Western blotting
Cells were lysed in lysis buffer (Cell Signaling Technology, Danvers, MA) containing 1 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich, St Louis, MO) and incubated on ice for 10 min. Lysates were then centrifuged at 12,000 rpm at 4°C for 10 min and the protein concentration of the supernatant was quantitated using the Bradford assay (BioRad, Hercules, CA). Aliquots containing 30 µg of protein were resolved by SDS-PAGE and electroblotted onto PVDF membranes (Millipore, Bedford, MA). The expression of Notch1 and β-actin were detected using specific anti-Notch1 (Santa Cruz Biotechnology, Santa Cruz, CA) and anti-β-actin (GE Healthcare, Waukesha, WI) antibodies.
Tumor growth assays
The experimental protocol and animal handling procedures were approved by the institutional animal ethics committee. To assess tumor growth, C666-1 cells stably expressing miR-200b or control were injected subcutaneously into the dorsal flank of female BALB/c nude mice aged 4 to 5 weeks (n = 5 per group). The Statistical analysis SPSS 13.0 software was used for statistical analysis. Data are expressed as the mean± SD from at least three independent experiments. Differences between groups were analyzed using Student's t-test when comparing only two groups, while one-way analysis of variance (ANOVA) was used when comparing more than two groups. The association between miR-200b and Notch1 expression was evaluated using Spearman's correlation analysis. Statistical differences with P < 0.05 were considered significant.
Results

miR-200b is downregulated in NPC cell lines and clinical specimens
To confirm the previous finding by Chen et al. [20] Fig. 2A) . Using the MTT assay as a measure of cell viability, we found that overexpression of miR-200b significantly inhibited cell viability, which was assumed to reflect cell numbers in the cultures and thus proliferation, while blocking miR- (Fig. 2C-E) . These results implied that miR-200b has a strong ability to suppress NPC cell growth.
miR-200b inhibits NPC cell migration and invasion in vitro
We next examined the effect of miR-200b on NPC cell migration and invasion. Using a wound-healing assay, we found that overexpression of miR-200b caused a suppression of cell migration in the C666-1 and 5-8F cell lines (Fig. 3A) . In contrast, the migration of these cells increased when endogenous miR-200b was knockdown (Fig. 3B) . To assess invasiveness of the NPC cell lines, we used the Matrigel transwell invasion assays. As shown in Fig. 3C , overexpression of miR-200b markedly reduced the invasive ability of C666-1 and 5-8F cells. Conversely, transfection with anti-miR-200b significantly increased cell invasiveness (Fig.  3D) . These results suggest that miR-200b can significantly suppress in vitro migration and invasion of NPC cells.
miR-200b directly targets Notch1 3'UTR
To determine the targets of miR-200b, we screened a large number of potential target proteins in a database library to identify promising miRNA binding seed sequences within 3' untranslated region (UTR). Using bioinformatic analyses (Targetscan, microRNA.org), we and western blotting, we found that both mRNA and protein expression of Notch1 were reduced by overexpression of miR-200b ( Fig. 4A and B) . We then used a luciferase assay to investigate whether miR-200b can functionally interact directly with the putative binding site in the 3'UTR of Notch1, using the reporter construct shown in Fig. 4C . In both C666-1 and 5-8F cells, cotransfection of the cells with wild or mutant Notch1 3'UTR together with miR200b or control lentivirus showed that miR-200b interacts with the wild Notch1 3'UTR to reduce luciferase expression (Fig. 4D) . Subsequently, we analyzed the expression of Notch1 in NPC tissues and normal nasopharyngeal epithelium. Notch1 expression was found to be significantly higher in NPC tissues compared to normal samples (Fig. 4E) , and analysis of miR-200b and Notch1 expression in 16 NPC specimens by Spearman's correlation analysis showed a significant inverse correlation (R = -0.652, P < 0.001; Fig. 4F ).
Notch1can reverse the inhibitory effect of miR-200b on NPC cell growth, migration and invasion
Since our results support the hypothesis that miR-200b acts via downregulation of Notch1 to inhibit cell growth and invasion, we tested whether Notch1 is a direct functional mediator of the inhibitory effect of miR-200b. C666-1 cells were transfected with Notch1 plasmid without the 3'UTR or control plasmid, in combination with miR-200b or control lentivirus transduction. The Notch1 construct without the 3'UTR is insensitive to miR-200b-mediated repression. Western blotting of the resultant cultures confirmed that miR-200b downregulated Notch1 expression, but that this could be restored by transfection with Notch1 plasmid (Fig. 5A) . Using the MTT assay, we observed that overexpression of Notch1 significantly rescued miR-200b-induced cell growth inhibition (Fig. 5B) . Furthermore, miR-200b overexpression significantly reduced C666-1 cell migration and invasion, while transfection with Notch1 reversed this inhibitory effect (Fig. 5C and D) . These results suggest that Notch1 is responsible for mediating the effects of miR-200b on NPC cell growth, migration and invasion. 
Discussion
In this study, we confirm that miR-200b is downregulated in NPC tissues and cell lines. We demonstrate that miR-200b regulates proliferation and invasion of NPC cells, suggesting that it may play a key role in tumorigenesis and metastasis.
Our initial analysis of miR-200b expression by qRT-PCR revealed that miR-200b expression was significantly downregulated in all the NPC cell lines tested, compared to the nonmalignant immortalized nasopharyngeal cell line NP69. To confirm that these results held true in nontransformed cells, we tested primary tissues from 16 cases of NPC and compared them with 10 normal tissue samples, and found that miR-200b expression was again significantly reduced in NPC. The data were similar to the findings in gastric cancer and glioma, in which miR-200b was downregulated [25, 26] . However, several other reports showed that miR-200b was upregulated in ovarian and bladder cancer [27, 28] . These controversial results demonstrated that the role of miR-200b was possibly tumor specific and highly dependent on its targets in different cancer cells.
We Previous studies have shown that expression of miRNAs is altered in many types of cancer, and have identified a variety of miRNA targets. These include EZH2 which is a target of miR-26a in rhabdomyosarcoma and lymphoma [16, 29, 30] , miR-29c which is downregulated in NPC cells and suppresses NPC cell migration and invasion by targeting TIAM1 [17] , miR-125b which suppresses liver cancer cell proliferation and metastasis by targeting oncogene LIN28B [31] , and miR-124 which has been shown to have an antiproliferative role in various cancers including cervical cancer and meduloblastoma [14, 32, 33] and to inhibit cell proliferation in gastric cancer through down-regulation of SPHK-1 [14] . Consequently we aimed to elucidate the role of miR-200b in NPC and to investigate and identify a potential intermediary.
Notch family members are important in controlling cell growth and invasion, and as such they play an important role in early embryonic development [34, 35] . Notch signaling involves a complex array of activator and repressor genes which are not yet completely understood, and activates a wide range of targets [36] . Notch1 has also been shown to be a target of several miRNAs, including miR-34a and miR-146a, through which these miRNAs regulate cancer cell proliferation, differentiation and invasion [24, 37, 38] . In this study, we investigated whether miR-200b acts via targeting of Notch1 in NPC. Using a luciferase reporter assay, we demonstrate conclusively that miR-200b directly targets Notch1 by binding to the potential 3'UTR binding site. Through this miR-200b acts to suppress growth and invasion of NPC cells.
It is worth noting that a single miRNA can influence the expression of various transcripts that have important roles in cancer development and progression [39] . Previous studies have reported several functional targets of miR-200b in cancer-related processes, including CREB1 in cell growth and ZEB2 in cell migration and invasion [25, 26] . Recently, Tang 
